首页> 美国卫生研究院文献>Infectious Disease Modelling >Assessing the utility of the tipping point ratio to monitor HIV treatment programmes in the era of universal access to ART
【2h】

Assessing the utility of the tipping point ratio to monitor HIV treatment programmes in the era of universal access to ART

机译:评估临界点比率在普遍获得抗逆转录病毒治疗时代监测艾滋病治疗方案的效用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe epidemiological tipping point ratio (TPR) has been suggested as a useful indicator to monitor the scale-up of antiretroviral treatment (ART) programmes and determine when scale-up is sufficient to control the epidemic. TPR has been defined as the ratio of yearly number of new HIV infections to the yearly number of new ART initiations or to the yearly net increase in the number of people on ART. It has been used to rank the progress of treatment programmes across countries, with the objective of reaching a TPR value under 1. Our study aims to assess if TPR alone can be used as an indicator of ART success across settings by comparing the expected changes in HIV incidence and ART coverage when TPR is maintained constant over time. In particular, we focus on the effect of ART initiation timing (emphasis on ART being initiated early or late during HIV progression) on the interpretation of the TPR.
机译:背景技术流行病学临界点比率(TPR)已被建议作为监测抗逆转录病毒治疗(ART)计划规模扩大并确定何时规模扩张足以控制流行病的有用指标。 TPR被定义为每年新感染艾滋病毒的人数与每年新发起抗病毒治疗的人数或每年接受抗病毒治疗的人数净增加的比率。它已被用来对各国治疗方案的进展进行排名,目的是使TPR值低于1。我们的研究旨在通过比较预期的TPR值,评估是否仅将TPR可以用作跨机构抗逆转录病毒疗法成功的指标。当TPR随时间保持恒定时,艾滋病毒的发病率和抗病毒治疗的覆盖率。特别是,我们重点关注ART起始时间(强调在HIV进展过程中的早期或晚期起始ART)对TPR的解释的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号